Subscribe to RSS
DOI: 10.1055/s-2008-1076797
© Georg Thieme Verlag Stuttgart · New York
Sexualität und Schizophrenie. Eine Übersicht
Publication History
Publication Date:
16 June 2008 (online)
Übersicht:
Der vorliegende Artikel gibt einen Überblick über den Forschungsstand zu sexuellem Erleben und Verhalten bei Menschen mit schizophrenen Störungen. Dabei werden geschlechtsspezifische Aspekte der Krankheitsentwicklung, die Bedeutung von Sexualität im Kontext einer schizophrenen Erkrankung und Auswirkungen veränderten sexuellen Erlebens und Verhaltens auf die psychiatrische Behandlung, die sexuelle Lebensqualität und die Therapiecompliance dargestellt. Die Autoren diskutieren ausführlich die Nebenwirkungen der antipsychotischen Medikation. Die Arbeit soll zu einer differenzierteren Wahrnehmung und selbstverständlicheren Integration sexueller Themen in die Behandlung von Patienten mit Schizophrenie beitragen.
Schlüsselwörter:
Antipsychotika - Compliance - Lebensqualität - Nebenwirkungen - Neuroleptika - Schizophrenie
Literatur
- 1 Aizenberg D, Modai I, Landa A, Gil-Ad I, Weizman A. Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine. J Clin Psychiatry. 2001; 62 541-544
- 2 Aizenberg D, Zemishlany Z, Dorfman-Etrog P, Weizman A. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry. 1995; 56 137-141
- 3 APA .Diagnostic & Statistical Manual of Mental Disorders. Fourth Edition. Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Publishing, 2000
- 4 Atmaca M, Kuloglu M, Tezcan E. A new atypical antipsychotic: quetiapine-induced sexual dysfunctions. Int J Impot Res. 2005; 17 201-203
- 5 Berger M. Psychische Erkrankungen. Klinik und Therapie. München Jena: Urban und Fischer, 2004
- 6 Bhui K, Puffet A, Herriot P. A survey of sexual problems amongst psychiatric inpatients. Soc Psychiatry Psychiatr Epidemiol. 1995; 30 73-77
- 7 Bitter I, Basson B R, Dossenbach M R. Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients. Int Clin Psychopharmacol. 2005; 20 19-21
- 8 Bobes J, Garc A PMP, Rejas J, Hern Ndez G, Garcia-Garcia M, Rico-Villademoros F, Porras A. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther. 2003; 29 125-147
- 9 Clayton A H, McGarvey E L, Clavet G J. The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull. 1997; 33 731-745
- 10 Cohen S, Scholz P. Sexualstörungen in der Behandlung depressiver Erkrankungen. Psychoneuro. 2004; 30 164-168
- 11 Cournos F, Guido J R, Coomaraswamy S, Meyer-Bahlburg H, Sugden R, Horwath E. Sexual activity and risk of HIV infection among patients with schizophrenia. Am J Psychiatry. 1994; 151 228-232
- 12 Darves-Bornoz J M, Lemperiere T, Degiovanni A, Gaillard P. Sexual victimization in women with schizophrenia and bipolar disorder. Soc Psychiatry Psychiatr Epidemiol. 1995; 30 78-84
- 13 Demyttenaere K, De Fruyt J, Sienaert P. Psychotropics and sexuality. Int Clin Psychopharmacol. 1998; 13 35-41
- 14 Derogatis L R. The Derogatis Interview for Sexual Functioning (DISF / DISF-SR): an introductory report. J Sex Marital Ther. 1997; 23 291-304
- 15 Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A, Shakhnovich T, Akram A, Pecenak J, McBride M, Treuer T. Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry. 2006; 21 251-258
- 16 Dossenbach M, Hodge A, Anders M, Molnar B, Peciukaitiene D, Krupka-Matuszczyk I, Tatu M, Bondar V, Pecenak J, Gorjanc T, McBride M. Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation. Int J Neuropsychopharmacol. 2005; 8 195-201
- 17 Fakhoury W K, Wright D, Wallace M. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. Int Clin Psychopharmacol. 2001; 16 153-162
- 18 Fan X, Henderson D C, Chiang E, Briggs L B, Freudenreich O, Evins A E, Cather C, Goff D C. Sexual functioning, psychopathology and quality of life in patients with schizophrenia. Schizophr Res. 2007; 94 119-127
- 19 Finn S E, Bailey J M, Schultz R T, Faber R. Subjective utility ratings of neuroleptics in treating schizophrenia. Psychol Med. 1990; 20 843-848
- 20 Fortier P, Mottard J P, Trudel G, Even S. Study of sexuality-related characteristics in young adults with schizophrenia treated with novel neuroleptics and in a comparison group of young adults. Schizophr Bull. 2003; 29 559-572
- 21 Friedman S, Harrison G. Sexual histories, attitudes, and behavior of schizophrenic and “normal” women. Arch Sex Behav. 1984; 13 555-567
- 22 Grube M, Weigand-Tomiuk H. [Sexual dysfunctions in a group of psychiatric in-patients]. Psychiatr Prax. 2002; 29 194-200
- 23 Hauch M. Paartherapie bei sexuellen Störungen. Stuttgart: Georg Thieme Verlag, 2006
- 24 Hellewell J S, Kalali A H, Langham S J. Patient satisfaction and acceptability of long-term treatment wih quetiapine. Int J Psychiatry Clin Prae. 1999; 3 105-113
- 25 Kelly D L. Treatment considerations in women with schizophrenia. J Womens Health (Larchmt). 2006; 15 1132-1140
- 26 Kelly D L, Conley R R. Evaluating sexual function in patients with treatment-resistant schizophrenia. Schizophr Res. 2003; 63 195-196
- 27 Kelly D L, Conley R R. A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Psychoneuroendocrinology. 2006; 31 340-346
- 28 Kinzel U, Weig W. Medikamente und ihre Nebenwirkungen auf die Sexualität. Psychoneuro. 2003; 30 53-56
- 29 Knegtering H, van der Moolen A E, Castelein S, Kluiter H, van den Bosch R J. What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?. Psychoneuroendocrinology. 2003; 28 109-123
- 30 Kockott G. Male and female sexuality-differences according to sex and age. Ther Umsch. 1994; 51 93-97
- 31 Kockott G. Psychotherapie sexueller Funktions- und Erlebensstörungen. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz. 2007; 50 11-18
- 32 Kockott G, Pfeiffer W. Sexual disorders in nonacute psychiatric outpatients. Compr Psychiatry. 1996; 37 56-61
- 33 Lambert M, Conus P, Eide P, Mass R, Karow A, Moritz S, Golks D, Naber D. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry. 2004; 19 415-422
- 34 Lambert M, Naber D. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs. 2004; 18 5-17 , ; discussion 41-43
- 35 Laumann E O, Paik A, Rosen R C. Sexual dysfunction in the United States: prevalence and predictors. Jama. 1999; 281 537-544
- 36 Lewis J, Scott E. The sexual education needs of those disabled by mental illness. Psychiatric Rehabilitation. 1997; 21 164-167
- 37 Lysaker P H, Meyer P S, Evans J D, Clements C A, Marks K A. Childhood sexual trauma and psychosocial functioning in adults with schizophrenia. Psychiatr Serv. 2001; 52 1485-1488
- 38 Macdonald S, Halliday J, Mac E T, Sharkey V, Farrington S, Wall S, McCreadie R G. Nithsdale Schizophrenia Surveys 24: sexual dysfunction. Case-control study. Br J Psychiatry. 2003; 182 50-56
- 39 Mallis D, Moisidis K, Kirana P S, Papaharitou S, Simos G, Hatzichristou D. Moderate and severe erectile dysfunction equally affects life satisfaction. J Sex Med. 2006; 3 442-449
- 40 Mason S E, Miller R. Safe sex and first-episode schizophrenia. Bull Menninger Clin. 2001; 65 179-193
- 41 McCann E. The expression of sexuality in people with psychosis: breaking the taboos. J Adv Nurs. 2000; 32 132-138
- 42 Miller L J, Finnerty M. Sexuality, pregnancy, and childrearing among women with schizophrenia-spectrum disorders. Psychiatr Serv. 1996; 47 502-506
- 43 Nestoros J N, Lehmann H E, Ban T A. Sexual behavior of the male schizophrenic: the impact of illness and medications. Arch Sex Behav. 1981; 10 421-442
- 44 Olfson M, Uttaro T, Carson W H, Tafesse E. Male sexual dysfunction and quality of life in schizophrenia. J Clin Psychiatry. 2005; 66 331-338
- 45 Peuskens J, Sienaert P, De Hert M. Sexual dysfunction: the unspoken side effect of antipsychotics. Eur Psychiatry. 1998; 23-30
- 46 Pfeiffer W, Kockott G, Fischl B, Schleuning G. Adverse effects of long-term psychopharmacologic therapy on sexual functions. Psychiatr Prax. 1991; 18 92-98
- 47 Pinderhughes C A, Grace E B, Reyna L J. Psychiatric disorders and sexual functioning. Am J Psychiatry. 1972; 128 1276-1283
- 48 Raboch J. Sexual development and life of psychiatric female patients. Arch Sex Behav. 1986; 15 341-353
- 49 Raja M, Azzoni A. Sexual behavior and sexual problems among patients with severe chronic psychoses. Eur Psychiatry. 2003; 18 70-76
- 50 Ramrakha S, Caspi A, Dickson N, Moffitt T E, Paul C. Psychiatric disorders and risky sexual behaviour in young adulthood: cross sectional study in birth cohort. Bmj. 2000; 321 263-266
- 51 Rosenberg K P, Bleiberg K L, Koscis J, Gross C. A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. J Sex Marital Ther. 2003; 29 289-296
- 52 Rosenberg S D, Lu W, Mueser K T, Jankowski M K, Cournos F. Correlates of adverse childhood events among adults with schizophrenia spectrum disorders. Psychiatr Serv. 2007; 58 245-253
- 53 Rowlands P. Schizophrenia and Sexuality. Sexual and Marital Therapy. 1995; 10 47-61
- 54 Saß H, Wittchen H U, Zaudig M, Houben I. Diagnostisches und Statistisches Manual Psychischer Störungen. - Textrevision - DSM-IV-TR. Göttingen Bern Toronto Seattle: Hogrefe Verlag für Psychologie, 2003
- 55 Schimmelmann B G, Paulus S, Schacht M, Tilgner C, Schulte-Markwort M, Lambert M. Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics. J Child Adolesc Psychopharmacol. 2005; 15 249-258
- 56 Smith S M, O'Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry. 2002; 181 49-55
- 57 Strauss B, Gross J. Psychotropic drug-induced changes in sexuality. Frequency and relevance in psychiatric practice. Psychiatr Prax. 1984; 11 49-55
- 58 Strauss B, Gross J. Empirical studies of sexual behavior of psychotic patients. A review. Fortschr Neurol Psychiatr. 1986; 54 248-258
- 59 Talakoub L, Munarriz R, Hoag L, Gioia M, Flaherty E, Goldstein I. Epidemiological characteristics of 250 women with sexual dysfunction who presented for initial evaluation. J Sex Marital Ther. 2002; 28 Suppl 1 217-224
- 60 Verhulst J, Schneidman B. Schizophrenia and sexual functioning. Hosp Community Psychiatry. 1981; 32 259-262
- 61 Volman L, Landeen J. Uncovering the sexual self in people with schizophrenia. J Psychiatr Ment Health Nurs. 2007; 14 411-417
- 62 Weisman A G, Nuechterlein K H, Goldstein M J, Snyder K S. Controllability perceptions and reactions to symptoms of schizophrenia: a within-family comparison of relatives with high and low expressed emotion. J Abnorm Psychol. 2000; 109 167-171
- 63 WHO .ICD-10: The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organisation (WHO), 1992
- 64 Wieck A, Haddad P M. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review. Br J Psychiatry. 2003; 182 199-204
- 65 Zajecka J. Strategies for the treatment of antidepressant-related sexual dysfunction. J Clin Psychiatry. 2001; 62 35-43
Dr. D. Kammerahl
Psychosen-Ersterkennungs- und Behandlungsprojekt (PEB)Klinik und Poliklinik für Psychiatrie und Psychotherapie Zentrum für Psychosoziale Medizin Universitätsklinikum Hamburg-Eppendorf
Martinistr. 52
20246 Hamburg
Email: d.kammerahl@uke.uni-hamburg.de